In general, multidrug therapy (MDT) completion rate and the change in disability levels before and after medical treatment are reported as outcomes in leprosy programmes. Changes in activity and social participation levels are rarely reported, possibly because the parameters are more diffi cult to measure.
INTRODUCTION
Leprosy is a chronic infectious disease and remains a major public health problem in some low-resource countries. India accounts for over 60 % of the global leprosy burden (World Health Organisation, 2016) . Leprosy aff ects the skin and peripheral nervous system and Lepra reactions and/or neuritis can occur before, during and after completion of multidrug therapy (MDT) (Jain et al, 2000) .If nerve involvement is not detected and treated in time, it leads to irreversible sensory, motor and autonomic impairments in a substantial proportion of people aff ected by leprosy (Van Brakel & Offi cer, 2008) . Moreover, these disabilities aff ect social participation of an aff ected individual (De Souza et al, 2016) .
Early detection of disease and prompt treatment with MDT is the main strategy to prevent impairments and disabilities among leprosy clients (WHO, 2013) . However, people still seek medical treatment long after the development of impairments and deformities. Even after completion of treatment, a signifi cant proportion of clients develop disability from neuritis and damage to aff ected limbs, requiring continued self-care to limit further secondary damage (Van Brakel et al, 2012) .
To cure leprosy, the World Health Organisation (WHO) prescribes regular administration of MDT over 6 to 12 months depending on the severity of the disease. This does not always mean that the client will not have any of the physical problems caused by leprosy. Even if he or she has visible physical impairments, he/she is still considered cured. Several dimensions of disability are recognised in the International Classifi cation of Functioning, Disability and Health (ICF): body structure (impairment), activity (activity limitations) and participation (participation restrictions). The classifi cation also recognises the role of physical and social environmental factors in aff ecting disability outcome (Van Brakel et al, 2012) .
Disability is more than mere physical dysfunction, and includes activity limitation, stigma, discrimination, and social participation restrictions (Stigter et al, 2000; Senturk & Sagduyu, 2004; Van Brakel et al, 2012; WHO, 2013) . In general, MDT completion rate and change in disability levels after medical treatment are reported as treatment outcomes in leprosy programmes. Persons aff ected by leprosy also experience limitations in activities and participation restrictions irrespective of the presence of impairments, and these specifi c issues usually receive only limited att ention during treatment (Malviya, 2014) . Therefore, changes in participation level need to be taken into account in any analyses of the social and economic burden of leprosy, as well as in evaluations of the general disability or in the outcomes of treatment completion. Since they are rarely considered as an outcome in leprosy programmes, the aim of this study is to determine the changes in social participation among leprosy-aff ected persons after completion of MDT and to study the factors associated with social participation.
METHOD Study Design
An observational study was conducted among newly-diagnosed persons aff ected with leprosy to assess any changes in social participation and disability level after completion of their medical treatment (MDT) for leprosy.
Study Sett ings
The study was conducted at the Leprosy Referral Hospital in Champa, situated in Janjgir district of Chhatt isgarh, India. This is a 60-bed, tertiary referral hospital for treatment of leprosy and its complications. Annually, over 350 new leprosyaff ected clients are registered for treatment and over 2,500 clients are treated for various complications due to leprosy. The electronic medical records system is in place since 2008, to store and retrieve clinical details of the clients, and every client is given a unique identifi cation number.
Participants
All newly-diagnosed leprosy-aff ected clients registered for MDT at the Leprosy Mission Community Hospital, between January and December 2014, were considered for inclusion in this study. Those who opted to continue their MDT at this hospital were included, while those who wanted to continue MDT at Primary Health Centres were excluded from the study. All those who completed the full course of MDT were included in the fi nal analysis.
Participants' demographic and clinical information such as type of leprosy, impairment status and disability level were obtained from their electronic medical records at the hospital.
Permission to conduct the study was obtained from the Research Committ ee, Bethesda Leprosy Mission Hospital, and Research Domain, The Leprosy Mission Trust India, New Delhi. Informed consent was obtained from the participants before their inclusion in the study.
Tools
Disability Grade -The level of disability of the leprosy-aff ected person was measured by World Health Organisation disability grade system (Brandsma& Van Brakel, 2003) . Clientswith leprosy are graded according to disabilities of the eyes, hands and feet. The highest grade of disability of any of these body sites is used as an overall indicator of the disability status of a person with leprosy (shown in Table 1 ).
Table 1: WHO Disability Grade
Hands and Feet Grade 0 No anaesthesia, no visible deformity or damage Grade 1 Anaesthesia present, but no visible deformity or damage Grade 2 Visible deformity or damage present Eyes Grade 0 No eye problem due to leprosy; no evidence of visual loss Grade 1 Eye problems due to leprosy present, but vision not severely aff ected as a result (vision: 6/60 or bett er; can count fi ngers at 6 metres) Grade 2 Severe visual impairment (vision worse than 6/60; inability to count fi ngers at 6 metres); also includes lagophthalmos, iridocyclitis and corneal opacities Participation Scale (P-Scale) -The Hindi version of the Participation Scale (P-Scale) was used to measure the level of social participation restriction (Van Brakel et al, 2006) . It is a validated questionnaire comprising18 items to measure client-perceived participation in people with disability due to various causes and in people aff ected by leprosy. The scores ranged from 0 to 90; people with scores from 0 -12 were considered as having no restrictions in social participation, with scores from 13 -22 as mild restrictions, with scores from 23 -32 as moderate restrictions, with scores from 33 -52 as serious restrictions, and with scores from 53 -90 as severe restrictions. To study the association between participation restriction and other variables, the score of the P-scale was dichotomized. Those with score of 12 and above as having 'some participation restriction' and those with score of below 12 as no participation restriction.
Data Collection
A physiotherapist experienced in leprosy rehabilitation and trained in basic interviewing techniques was assigned to recruit participants and conduct interviews. The interview was always conducted in a separate room to maintain privacy of the participants. Special att ention was paid to each participant, especially whenever they shared any distressing experience because of the diagnosis of leprosy and its complications, and appropriate counselling was given. Assessment of participation using P-Scale was done within 1 or 2 months from the time of diagnosis and repeated on completion of MDT. Assessment of nerve function impairment and disability grade was assigned as per WHO guidelines before the start of MDT and at the time of completion of MDT, and at regular intervals during treatment. The rehabilitation and awareness programme was provided to all the participants.
Data Analysis
Data were entered into Excel and analysed using SPSS. A descriptive analysis and chi-square test were performed to study the association between the variables.
RESULTS
A total of 158 clients were registered for MDT during the study period. The 50 clients who opted to continue MDT at their nearest Primary Health Centre (PHC) were given referrals and the remaining 108 clients were included in the study. At the end of the study period the 90 clients who completed their full course of MDT were included in the fi nal analysis. A total of 18 clients were lost to follow-up; hence they were excluded from analysis.
Demographic and clinical profi le of study participants are given in Table2. Of the 90 study participants, 63% were male. The mean (SD) age of participants was 35 years (15.8). Among them, 64% were literate and 67% were in gainful employment (farmers, daily wagers, and skilled labour). Majority of the participants (83%) had multibacillary leprosy (MB), 26% had visible impairments (Grade 2 disability) and 44% had positive slit-skin smear, at the time of diagnosis. On completion of MDT with steroid therapy for those who had reaction and neuritis, the proportion of clients who had no restriction increased from 76% to 93%, at before and after MDT respectively; proportion of clients with mild restriction decreased from 18% to 4%; and proportion of clients with moderate to extreme restriction reduced from 6% to 2%. Overall, 22 participants (24%) had participation restriction at the time of diagnosis, but at the end of MDT, it declined to 6 participants (7%), as shown in Fig1.
Figure 1
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Relationship of participation restriction with demographic factors and disease factors is shown in Table3. Gender, age and occupation were not associated with participation restriction, either before or after MDT. The MB clients had more participation restriction before and after MDT, whereas no participation restriction was observed among pauci-bacillary (PB) clients. Before MDT, signifi cant association was observed between participation restriction and education level (p <0.05) and type of leprosy (p<0.05). It was no longer signifi cant at post-MDT treatment. However, association was not signifi cant post-MDT treatment. The analysis revealed that before MDT, people above 30 years of age had more restriction in participation than those below 30 years, and illiterate people had more restriction in participation than the literate ones.
Signifi cant association was observed between participation restriction and the disability level, both before and after MDT assessments. Those with visible impairments (Grade 2 disability) had more restriction as compared to those with no impairments or no visible impairments (Grade 0 or 1 disability). The proportion of participants with some restriction reduced noticeably from 78% before starting MDT to 26% after completion of MDT (Table 3) . 
DISCUSSION
According to the International Classifi cation of Functioning, Disability and Health domains (ICF), disability is a term that concerns impairment, limitation of activity and restriction of participation. One of its dimensions is social participation which is the involvement in life situations, including domains such as education and applying knowledge, communication, mobility, self-care, domestic life, interpersonal interactions, social and civic life, and major life area (Van Brakel et al, 2006) . This study reports the changes in social participation among clients with leprosy, before and after MDT.
Among the clients with Grade 2 disability, there was a notable reduction in the proportion of those with participation restriction, after MDT treatment.
The restriction level is comparable with studies from other countries. In Brazil, Nardi et al (2011) evaluated the degree of disability and social restriction after completion of multidrug therapy and found that 32% of persons had some degree of disability and 35% had participation restriction. Another Brazilian study by Barbosa et al (2008) found that 41% of persons had some degree of disability and 7% had participation restriction.
Studies have found that the presence of physical disability, Grade 2 according to WHO classifi cation, was associated with social participation restriction (Barbosa et al, 2008; Sinha et al, 2010; Nardi et al, 2011; De Castro et al, 2014) . A study from India (Singh et al, 2009 ) observed that the people aff ected with leprosy are restricted by themselves from social participation, with the progression of the disease. Nardi et al (2011) conducted a study in Brazil, and found 68% among those with Grade 2 disabilities had participation restriction after completion of MDT. In the present study, participation restriction was present among 78% of those with Grade 2 disabilities pre-MDT and it declined to 26% post-MDT and treatment for complications due to leprosy.
The study by Nardi et al (2011) from Brazil, found 27% restriction in males and 23% in females after MDT completion, while another Brazilian study by Barbosa et al (2008) observed that participation restriction among males and females was 31% and 39%, respectively. A study from India by Singh et al (2009) found that females had more restriction than males, both in moderate and severe participation restriction categories. In the present study, participation restriction was more among males (30%) than female participants (15%) at the start of MDT and it reduced after completion of MDT to 9% in males and 3% in females. However, there is no statistical association found among gender in participation restriction.
In the present study, majority of participants were diagnosed with multibacillary leprosy (83%). Nearly half of them (44%) had positive bacterial index and a quarter of the clients reported with Grade 2 disabilities at the time of starting MDT. Singh et al (2009) reported that timely access to MDT prevents the participants from falling prey to deformity but those participants who fail to get treatment on time develop deformity and as deformity increases, the level of participation restriction also increases.
De Castro et al (2014) in Brazil, reported 31% restriction in MB and 17% in paucibacillary leprosy (PB) after completion of MDT. In the present study also, only 29% of MB participants had participation restriction before start of MDT, which reduced to 8% after completion of MDT. There was no restriction observed among PB clients, either before or after MDT. This suggests that early detection and appropriate and timely treatment will reduce the complications caused by leprosy and the resulting participation restriction, even among those with severe forms of the disease like MB leprosy.
Limitations
This study had a few limitations. The cohort is relatively small, heterogeneous (disease classifi cation and disability status at start of treatment) and the followup was relatively short. Impact of disability grade at start of treatment, reactions and interventions may change activity/participation problems beyond the MDT period. The cohort seems too small to determine signifi cance when considering age and gender, or when taking into account disability grade and leprosy status at the start of treatment.
CONCLUSION
Timely detection and early initiation of multidrug therapy and management of reaction and/or neuritis improves the participation level of clients, irrespective of the severity or classifi cation of the disease. Participation restriction was independent of age, gender and occupation. Presence of visible deformities at the time of diagnosis was found to be signifi cantly associated with participation restriction. Early detection and management through regular monitoring of leprosy clients would reduce the risk of participation restriction among them.
